Comprehensive testicular cancer care including seminoma and non-seminoma with chemotherapy, surveillance protocols, and high cure rates.
Expert management of seminoma and non-seminoma testicular cancer with BEP chemotherapy, surveillance protocols, and comprehensive multidisciplinary care. We achieve excellent cure rates even in advanced disease.
CT chest/abdomen/pelvis, MRI, and PET-CT for accurate staging and treatment planning.
AFP, β-hCG, and LDH monitoring for diagnosis, staging, and treatment response assessment.
Orchiectomy specimen analysis, immunohistochemistry, and histological classification.
Painless lump/swelling in a testicle; change in size/consistency; heaviness in the scrotum.
Dull ache in groin/abdomen, sudden pain from torsion/bleeding within a tumor.
Back pain, breast tenderness (gynecomastia), fatigue, or weight loss in advanced disease.
Undescended testicle (even if surgically corrected) increases lifetime risk.
History in a first-degree relative or previous testicular cancer raises risk.
Most common in young men (15–35 years); certain ethnicities have higher risk.
Regular imaging, tumor marker monitoring, and clinical follow-up for early detection of recurrence.
Collaboration with urologic surgery, radiation oncology, and fertility specialists.
Managing treatment side effects, fertility preservation, and maintaining quality of life.